Technical Analysis for BNTX - BioNTech SE

Grade Last Price % Change Price Change
B 149.48 -1.36% -2.06
BNTX closed down 1.36 percent on Monday, April 19, 2021, on 2.0 times normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical BNTX trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Calm After Storm Range Contraction 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -1.36%
Pocket Pivot Bullish Swing Setup -1.36%
Older End-of-Day Signals for BNTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 17 hours ago
Gap Down Closed about 17 hours ago
Rose Above Previous Day's High about 17 hours ago
New 52 Week High about 17 hours ago
3x Volume Pace about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Disease Infectious Diseases Drug Discovery In Vitro Biomarker Autoimmunity Allergy Immune Disorders Biomarkers Autoimmune Disorders Medical Terminology Allergies Diagnostic Devices In Vitro Diagnostic Device In Vitro Diagnostic Devices

Is BNTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 156.81
52 Week Low 43.0
Average Volume 1,698,902
200-Day Moving Average 94.05
50-Day Moving Average 111.59
20-Day Moving Average 116.17
10-Day Moving Average 129.26
Average True Range 6.77
ADX 32.15
+DI 50.27
-DI 8.99
Chandelier Exit (Long, 3 ATRs ) 136.50
Chandelier Exit (Short, 3 ATRs ) 113.31
Upper Bollinger Band 150.18
Lower Bollinger Band 82.16
Percent B (%b) 0.99
BandWidth 58.55
MACD Line 10.21
MACD Signal Line 5.85
MACD Histogram 4.3661
Fundamentals Value
Market Cap 35.99 Billion
Num Shares 241 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -265.46
Price-to-Sales 143.59
Price-to-Book 25.52
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 164.24
Resistance 3 (R3) 165.04 160.93 161.78
Resistance 2 (R2) 160.93 157.17 160.53 160.96
Resistance 1 (R1) 155.20 154.85 158.07 154.40 160.14
Pivot Point 151.09 151.09 152.52 150.68 151.09
Support 1 (S1) 145.36 147.33 148.22 144.56 138.82
Support 2 (S2) 141.25 145.01 140.84 138.00
Support 3 (S3) 135.52 141.25 137.18
Support 4 (S4) 134.72